Skip Navigation
National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Personal tools
You are here: Home News ORIP/DPCPSI/OD Symposium on Animal Models and Personalized Medicine October 28-29, 2013
Navigation
 
Document Actions

ORIP/DPCPSI/OD Symposium on Animal Models and Personalized Medicine October 28-29, 2013

Register at  http://events.SignUp4.com/LMAMPM2013


You are invited to an NIH Symposium on Animal Models and Personalized Medicine on October 28th and 29th, 2013 at the Natcher Conference Center, NIH, in Bethesda, MD. The meeting is devoted to the discussion of the current status, future developments, and the most urgent needs for the application of advanced animal models for targeting personalized disease phenotypes. The purpose of the symposium is to provide an opportunity for biologists and clinicians to exchange ideas and to interact and enhance collaborations in advancing animal disease models to overcome some of the most difficult challenges in the post-genomic era, namely, the validation of disease-associated genetic variations and biomarkers in humans, reduction of drug candidate attrition, and development of new types of individualized therapies for both monogenic and complex human disorders. This symposium is sponsored by the Office of Research Infrastructure Programs, DPCPSI/OD/NIH.

 

Session Topics: The Use of Comparative and Functional Genomics to Build Animal Models of Human Diseases, Technological Advances and Available Resources for Building Predictive Animal Models, Using Personalized Animals for Drug Discovery and Biomarker Development, Which Human Disease Conditions Are the Best Candidates for Use of Personalized Animal Models? How Personalized Animal Models Can Guide Clinical Trials

Confirmed speakers include: Barbacid M. (Spanish National Cancer Research Center, Spain); Blumberg R.S. (Harvard Medical School, MA); Cagan R. (Mount Sinai Hospital, NY); Duyk G. (EPIRUS Biopharmaceuticals Inc, MA); Ellisman M. (UC San Diego, CA); Feinberg A. (Johns Hopkins University, MD); FitzGerald G.A. (University of Pennsylvania, PA); Greiner D.L. (University of Massachusetts, MA); Hazel S. (MIT, MA); Karayiorgou M. (Columbia University, NY); Lloyd K. (UC Davis, CA); MacRae C. (Harvard Medical School, MA); Pandolfi P. (Harvard Medical School, MA); Schofield P.N. (University of Cambridge, UK); Shultz L. (Jackson Lab., MN); Snyder M. (Stanford University, CA); Sykes M. (Columbia University, NY); Tuveson D. (CSH, NY); Valle D. (Johns Hopkins University, MD); Wurst W. (Institute of Developmental Genetics, Munchen, Germany); Zon L. (Harvard Medical School, MA).

For more information on meeting logistics and registration, contact: RegenerativeMedicine@lmbps.com

 

For programmatic questions contact Oleg Mirochnitchenko at Oleg.Mirochnitchenko@nih.gov